Themed collection Articles behind our 2025 journal covers


Enhancing the radionuclide theranostic concept through the radiohybrid approach
The radiohybrid concept: a significant extension of radionuclide theranostics – a fast-growing field in radiopharmaceutical sciences offering personalised and precise treatment options by combining specific diagnosis with targeted endoradiotherapy.
RSC Med. Chem., 2025,16, 1856-1864
https://doi.org/10.1039/D4MD00591K
Breaking the energy chain: importance of ATP synthase in Mycobacterium tuberculosis and its potential as a drug target
Inhibitors of mycobacterial ATP synthase, such as bedaquiline, TBAJ-587, TBAJ-876, squaramides, GaMF1, and DeMF1, break the energy metabolism and effectively inhibit Mtb, offering promising strategies against mycobacterial infections.
RSC Med. Chem., 2025,16, 1476-1498
https://doi.org/10.1039/D4MD00829D
Advances in the development of Wnt/β-catenin signaling inhibitors
The Wnt/β-catenin signaling pathway plays a critical role in various biological processes, including cell proliferation, differentiation, and tissue homeostasis.
RSC Med. Chem., 2025,16, 984-999
https://doi.org/10.1039/D4MD00749B

Application of a bivalent “click” approach to target tyrosyl-DNA phosphodiesterase 1 (TDP1)
Application of copper-catalyzed azide–alkyne cycloaddition (CuAAC) “click” reactions assemble bivalent proteolysis-targeting chimeras (PROTACs) constituents targeting tyrosyl-DNA phosphodiesterase 1 (TDP1).
RSC Med. Chem., 2025,16, 1969-1985
https://doi.org/10.1039/D4MD00824C
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study
Short MD simulations help identify the putative bioactive conformation of small molecule agonists at the NOP receptor providing useful information for the structure-based design of novel analgesic drugs.
RSC Med. Chem., 2025,16, 1584-1599
https://doi.org/10.1039/D4MD00747F
Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Several fused-thiazole derivatives have been studied for antimelanoma properties. Lead compounds are effective tumor growth inhibitors in mice, which are potent β- and γ-actin cytoskeleton inhibitors with a probable mechanism of β-PARVIN inhibition.
RSC Med. Chem., 2025,16, 1105-1130
https://doi.org/10.1039/D4MD00719K
Design, synthesis and mechanistic insights into triclosan derived dimers as potential anti-plasmodials
In pursuit of novel anti-plasmodial agents, a library of triclosan-based dimers both with and without a 1H-1,2,3 triazole core were designed, synthesized and evaluated in order to achieve a multitargeted approach.
RSC Med. Chem., 2025,16, 709-720
https://doi.org/10.1039/D4MD00494A
Generation and capture of naphthoquinonynes: a new frontier in the development of trypanocidal quinones via aryne chemistry
This article presents A-ring functionalized quinones via a modern and efficient new strategy involving the generation and capture of benzyne quinones and their evaluation against Trypanosoma cruzi.
RSC Med. Chem., 2025,16, 694-708
https://doi.org/10.1039/D4MD00558A
Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer
Non-small cell lung cancer (NSCLC), the leading cause of cancer-related mortality worldwide, poses a formidable challenge due to its heterogeneity and the emergence of resistance to targeted therapies.
RSC Med. Chem., 2025,16, 77-97
https://doi.org/10.1039/D4MD00553H
About this collection
This collection brings together all of the research and review-type articles behind our 2025 journal covers, showcasing the wide range of research found in the journal. If your article has been accepted for publication, and you are interested in highlighting your research on one of our covers, please do contact the Editorial Team for further information.